FREMONT, Calif., Feb. 25, 2022 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM” or the “Company”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today reported financial results for its fourth quarter and fiscal year ended December 31, 2021.
“2021 was an exceptional and transformative year for ACM, with solid financial performance, operational excellence, and execution of our strategic plan,” said ACM’s President and Chief Executive Officer Dr. David Wang. “Our results demonstrate the effectiveness of ACM’s multi-product strategy, with strong growth from our flagship cleaning tools, and significant increases from electrochemical plating and advanced packaging products.”
Dr. Wang continued, “We expanded our customer base, ramped production of new products, and secured orders for evaluation tools from several major semiconductor manufacturers. In November, we raised $545 million in net proceeds through the STAR Market IPO of our subsidiary ACM Research Shanghai. We plan to deploy this capital to accelerate the introduction of new products, add resources to win new major global customers, and continue construction of our Lingang R&D center and production facility. We believe that the STAR Market listing, combined with the listing of ACM’s Class A common stock on the Nasdaq Global Market, provides a strong foundation to accelerate our mission to become a global player in the semiconductor equipment industry.”
“Looking forward to 2022, we anticipate solid growth from our core cleaning products, a continuation of our strong electrochemical plating product cycle, and the initial ramp of our furnace products. We are committed to gaining additional share of the $8 billion market addressed by our current product offerings, and we believe we are on track to double our addressable market opportunity with the upcoming introduction of two new product categories.”
Three Months Ended December 31, | |||||||||||||||
GAAP | Non-GAAP(1) | ||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
(dollars in thousands, except EPS) | |||||||||||||||
Revenue | $ | 95,142 | $ | 45,562 | $ | 95,142 | $ | 45,562 | |||||||
Gross margin | 47.8 | % | 43.2 | % | 47.9 | % | 43.3 | % | |||||||
Income from operations | $ | 19,126 | $ | 5,432 | $ | 20,420 | $ | 6,737 | |||||||
Net income attributable to ACM Research, Inc. | $ | 15,565 | $ | 8,529 | $ | 18,069 | $ | 6,230 | |||||||
Basic EPS | $ | 0.80 | $ | 0.46 | $ | 0.93 | $ | 0.34 | |||||||
Diluted EPS (2) | $ | 0.70 | $ | 0.39 | $ | 0.81 | $ | 0.29 | |||||||
Year Ended December 31, | |||||||||||||||
GAAP | Non-GAAP(1) | ||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
(dollars in thousands, except EPS) | |||||||||||||||
Revenue | $ | 259,751 | $ | 156,624 | $ | 259,751 | $ | 156,624 | |||||||
Gross margin | 44.2 | % | 44.4 | % | 44.4 | % | 44.5 | % | |||||||
Income from operations | $ | 38,702 | $ | 21,492 | $ | 43,819 | $ | 27,120 | |||||||
Net income attributable to ACM Research, Inc. | $ | 37,757 | $ | 18,780 | $ | 42,267 | $ | 23,798 | |||||||
Basic EPS | $ | 1.96 | $ | 1.03 | $ | 2.20 | $ | 1.31 | |||||||
Diluted EPS (2) | $ | 1.73 | $ | 0.89 | $ | 1.94 | $ | 1.12 | |||||||
(1) Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted EPS, also exclude non-cash change in fair value of financial liabilities and unrealized gain on trading securities.
(2) Diluted EPS includes an impact of $108,000 in the fourth quarter and the full year 2021 from dilutive shares of ACM Research (Shanghai), Inc.
Outlook
For fiscal year 2022, the Company expects revenue to be in the range of $365 million to $405 million, an increase from guidance provided in a press release announcement made on January 4, 2022. This expectation assumes, among other factors, improvement with respect to the global COVID-19 pandemic and stability in US-China trade policy. The range of ACM’s 2022 outlook reflects, among other things, various spending scenarios for the production ramps of key customers, the absence of unexpected disruptions in ACM’s supply chain, and the timing of acceptances for first tools under evaluation in the field.
Operating Highlights and Recent Announcements
Full Year 2021 Financial Summary
Fourth Quarter 2021 Financial Summary
Conference Call Details
A conference call to discuss results will be held on Friday, February 25, 2022, at 8:00 a.m. Eastern Time (9:00 p.m.China Time). Dial-in details for the call are as follows. Please reference conference ID 9396606.
Phone Number | Toll-Free Number | |
United States | +1 (661) 567-1217 | +1 (833) 562-0137 |
Hong Kong | +852 5819 4851 | +852 8009 66253 |
Mainland China | +86 8008700169+86 4006828609 |
A recording of the webcast will be available on the investor page of the ACM website at www.acmrcsh.com for one week following the call.
Use of Non-GAAP Financial Measures
ACM presents non-GAAP gross margin, operating expenses, operating income, net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share as supplemental measures to GAAP financial measures regarding ACM’s operational performance. These supplemental measures exclude the impact of stock-based compensation, which ACM does not believe is indicative of its core operating results. In addition, non-GAAP net income attributable to ACM Research, Inc. and basic and diluted EPS exclude non-cash change in fair value of financial assets and liabilities and unrealized gain on trading securities, which ACM also believes are not indicative of its core operating results. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided below under “Reconciliation of Non-GAAP to GAAP Financial Measures.”
ACM believes these non-GAAP financial measures are useful to investors in assessing its operating performance. ACM uses these financial measures internally to evaluate its operating performance and for planning and forecasting of future periods. Financial analysts may focus on and publish both historical results and future projections based on the non-GAAP financial measures. ACM also believes it is in the best interests of investors for ACM to provide this non-GAAP information.
While ACM believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and should be considered only in conjunction with ACM’s consolidated financial statements prepared in accordance with GAAP.
Forward-Looking Statements
Certain statements contained in the second, third and fourth paragraphs of this press release, under the heading “Outlook” above, and in the third and fifth bullet under “Operating Highlights and Recent Announcements” above are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding the intent, belief and current expectations with respect to: the demand for ACM’s tools, including specifically in fiscal year 2022; the expansion in 2022 of ACM’s product offering, production capacity and base of major customers; and the timing and ability of ACM to secure orders from new customers. Those statement are expectations only, reflect management's current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, the following, any of which could be exacerbated even further by the continuing COVID-19 outbreak in China and globally: anticipated customer orders or identified market opportunities may not grow or develop as anticipated; customer orders already received may be postponed or canceled; ACM may be unable to obtain the qualification and acceptance of its delivered tools when anticipated or at all, which would delay or preclude ACM’s recognition of revenue from the sale of those tools; suppliers may not be able to meet ACM’s demands on a timely basis; ACM’s technologies and tools may not gain market acceptance; ACM may be unable to compete effectively by, among other things, enhancing its existing tools, adding additional production capacity and engaging additional major customers; volatile global economic, market, industry and other conditions could result in sharply lower demand for products containing semiconductors and for the Company's products and in disruption of capital and credit markets; trade regulations, currency fluctuations, political instability and war may materially adversely affect ACM due to its substantial non-U.S. customer and supplier base and its substantial non-U.S. manufacturing operations. ACM cannot guarantee any future results, levels of activity, performance or achievements. ACM undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations regarding these forward-looking statements or the occurrence of unanticipated events.
About ACM Research, Inc.
ACM develops, manufactures and sells semiconductor process equipment for single-wafer or batch wet cleaning, electroplating, stress-free polishing and thermal processes that are critical to advanced semiconductor device manufacturing, as well as wafer-level packaging. The Company is committed to delivering customized, high performance, cost-effective process solutions that semiconductor manufacturers can use in numerous manufacturing steps to improve productivity and product yield.
© ACM Research, Inc. SAPS, ULTRA C and the ACM Research logo are trademarks of ACM Research, Inc. For convenience, these trademarks appear in this press release without ™ symbols, but that practice does not mean that ACM will not assert, to the fullest extent under applicable law, its rights to the trademarks.
For investor and media inquiries, please contact: | |
In the United States: | The Blueshirt Group |
Yujia Zhai | |
+1 (860) 214-0809 | |
yujia@blueshirtgroup.com | |
In China: | The Blueshirt Group Asia |
Gary Dvorchak, CFA | |
+86 (138) 1079-1480 | |
gary@blueshirtgroup.com |
ACM RESEARCH, INC. | ||||||
Condensed Consolidated Balance Sheets | ||||||
December 31, 2021 | December 31, 2020 | |||||
(Unaudited) | ||||||
(In thousands, except share and per share data) | ||||||
Assets | ||||||
Current assets: | ||||||
Cash and cash equivalents | $ | 563,067 | $ | 71,766 | ||
Trading securities | 29,498 | 28,239 | ||||
Accounts receivable, less allowance for doubtful accounts of $0 as of December 31, 2021 and December 31, 2020 | 105,553 | 56,441 | ||||
Income tax recoverable | 1,082 | - | ||||
Other receivables | 18,979 | 9,679 | ||||
Inventories | 218,116 | 88,639 | ||||
Prepaid expenses | 16,639 | 5,892 | ||||
Total current assets | 952,934 | 260,656 | ||||
Property, plant and equipment, net | 14,042 | 8,192 | ||||
Land use right, net | 9,667 | 9,646 | ||||
Operating lease right-of-use assets, net | 4,182 | 4,297 | ||||
Intangible assets, net | 477 | 554 | ||||
Deferred tax assets | 13,166 | 11,076 | ||||
Long-term investments | 12,694 | 6,340 | ||||
Other long-term assets | 45,017 | 40,496 | ||||
Total assets | 1,052,179 | 341,257 | ||||
Liabilities and Stockholders’ Equity | ||||||
Current liabilities: | ||||||
Short-term borrowings | 9,591 | 26,147 | ||||
Current portion of long-term borrowings | 2,410 | 1,591 | ||||
Accounts payable | 101,350 | 35,603 | ||||
Advances from customers | 52,824 | 17,888 | ||||
Deferred revenue | 3,180 | 1,343 | ||||
Income taxes payable | 254 | 31 | ||||
FIN-48 payable | 2,282 | 83 | ||||
Other payables and accrued expenses | 31,735 | 18,805 | ||||
Current portion of operating lease liability | 2,313 | 1,417 | ||||
Total current liabilities | 205,939 | 102,908 | ||||
Long-term borrowings | 22,957 | 17,979 | ||||
Long-term operating lease liability | 1,869 | 2,880 | ||||
Deferred tax liability | 1,302 | 1,286 | ||||
Other long-term liabilities | 8,447 | 8,034 | ||||
Total liabilities | 240,514 | 133,087 | ||||
Commitments and contingencies | ||||||
Stockholders’ equity: | ||||||
Common stock – Class A, par value $0.0001: 150,000,000 shares authorized as of December 31, 2021 and 50,000,000 shares authorized as of December 31, 2020; 17,869,643 shares issued and outstanding as of December 31, 2021 and 16,896,693 shares issued and outstanding as of December 31, 2020 | 2 | 2 | ||||
Common stock–Class B, par value $0.0001: 5,307,816 shares authorized as of December 31, 2021 and 2,409,738 shares authorized as of December 31, 2020; 1,695,938 shares issued and outstanding as of December 31, 2021 and 1,802,606 shares issued and outstanding as of December 31, 2020 | - | - | ||||
Additional paid in capital | 595,049 | 102,004 | ||||
Accumulated surplus | 72,044 | 34,287 | ||||
Accumulated other comprehensive income | 9,109 | 4,857 | ||||
Total ACM Research, Inc. stockholders’ equity | 676,204 | 141,150 | ||||
Non-controlling interests | 135,461 | 67,020 | ||||
Total stockholders’ equity | 811,665 | 208,170 | ||||
Total liabilities and stockholders’ equity | $ | 1,052,179 | $ | 341,257 | ||
ACM RESEARCH, INC. | ||||||||||||||||
Condensed Consolidated Statements of Operations and Comprehensive Income | ||||||||||||||||
Three Months EndedDecember 31, | Year EndedDecember 31, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
(Unaudited) | (Unaudited) | |||||||||||||||
( In thousands, except share and pershare data) | ( In thousands, except share and pershare data) | |||||||||||||||
Revenue | $ | 95,142 | $ | 45,562 | $ | 259,751 | $ | 156,624 | ||||||||
Cost of revenue | 49,696 | 25,888 | 144,895 | 87,025 | ||||||||||||
Gross profit | 45,446 | 19,674 | 114,856 | 69,599 | ||||||||||||
Operating expenses: | ||||||||||||||||
Sales and marketing | 9,273 | 5,249 | 26,733 | 16,773 | ||||||||||||
Research and development | 12,914 | 5,878 | 34,207 | 19,119 | ||||||||||||
General and administrative | 4,133 | 3,115 | 15,214 | 12,215 | ||||||||||||
Total operating expenses, net | 26,320 | 14,242 | 76,154 | 48,107 | ||||||||||||
Income from operations | 19,126 | 5,432 | 38,702 | 21,492 | ||||||||||||
Interest income | 392 | 63 | 505 | 897 | ||||||||||||
Interest expense | (191 | ) | (371 | ) | (765 | ) | (982 | ) | ||||||||
Change in fair value of financial liability | - | - | - | (11,964 | ) | |||||||||||
Unrealized gain on trading securities | (1,210 | ) | 3,604 | 607 | 12,574 | |||||||||||
Other income (expense), net | 52 | (2,444 | ) | (631 | ) | (3,377 | ) | |||||||||
Equity income in net income of affiliates | 3,601 | 116 | 4,637 | 655 | ||||||||||||
Income before income taxes | 21,770 | 6,400 | 43,055 | 19,295 | ||||||||||||
Income tax benefit (expense) | (3,155 | ) | 2,798 | (134 | ) | 2,382 | ||||||||||
Net income | 18,615 | 9,198 | 42,921 | 21,677 | ||||||||||||
Less: Net income attributable to non-controlling interests and redeemable non-controlling interests | 3,050 | 669 | 5,164 | 2,897 | ||||||||||||
Net income attributable to ACM Research, Inc. | $ | 15,565 | $ | 8,529 | $ | 37,757 | $ | 18,780 | ||||||||
Comprehensive income: | ||||||||||||||||
Net income | 18,615 | 9,198 | 42,921 | 21,677 | ||||||||||||
Foreign currency translation adjustment | 3,436 | 6,394 | 4,695 | 10,493 | ||||||||||||
Comprehensive Income | 22,051 | 15,592 | 47,616 | 32,170 | ||||||||||||
Less: Comprehensive income attributable to non-controlling interests and redeemable non-controlling interests | 3,136 | 3,244 | 5,607 | 6,858 | ||||||||||||
Comprehensive income attributable to ACM Research, Inc. | $ | 18,915 | $ | 12,348 | $ | 42,009 | $ | 25,312 | ||||||||
Net income attributable to ACM Research, Inc. per common share: | ||||||||||||||||
Basic | $ | 0.80 | $ | 0.46 | $ | 1.96 | $ | 1.03 | ||||||||
Diluted | $ | 0.70 | $ | 0.39 | $ | 1.73 | $ | 0.89 | ||||||||
Weighted average common shares outstanding used in computing per share amounts: | ||||||||||||||||
Basic | 19,529,462 | 18,557,085 | 19,218,236 | 18,233,361 | ||||||||||||
Diluted | 22,108,607 | 21,794,203 | 21,785,572 | 21,183,469 | ||||||||||||
ACM RESEARCH, INC. | |||||||||||
Total Revenue by Product Category, by Equipment Type and by Region | |||||||||||
Three Months EndedDecember 31, | Year EndedDecember 31, | ||||||||||
Total Revenue By Product Category | 2021 | 2020 | 2021 | 2020 | |||||||
Single wafer cleaning, Tahoe and semi-critical cleaning equipment | $ | 61,886 | $ | 36,780 | $ | 189,208 | $ | 131,248 | |||
ECP (front-end and packaging), furnace and other technologies | 19,460 | 4,003 | 33,210 | 13,343 | |||||||
Advanced packaging (excluding ECP), services & spares | 13,796 | 4,779 | 37,333 | 12,033 | |||||||
$ | 95,142 | $ | 45,562 | $ | 259,751 | $ | 156,624 | ||||
Three Months EndedDecember 31, | Year EndedDecember 31, | ||||||||||
Total Revenue Front-end and Back-End | 2021 | 2020 | 2021 | 2020 | |||||||
Wet cleaning and other front-end processing tools | $ | 74,946 | $ | 37,358 | $ | 202,268 | $ | 136,317 | |||
Advanced packaging, other processing tools, services and spares | 20,196 | 8,204 | 57,483 | 20,307 | |||||||
$ | 95,142 | $ | 45,562 | $ | 259,751 | $ | 156,624 | ||||
Three Months EndedDecember 31, | Year EndedDecember 31, | ||||||||||
Total Revenue by Region | 2021 | 2020 | 2021 | 2020 | |||||||
Mainland China | $ | 94,296 | $ | 44,185 | $ | 258,615 | $ | 154,359 | |||
Other Regions | 846 | 1,377 | 1,136 | 2,265 | |||||||
$ | 95,142 | $ | 45,562 | $ | 259,751 | $ | 156,624 | ||||
ACM RESEARCH, INC.Reconciliation of GAAP to Non-GAAP Financial Measures
As described under “Use of Non-GAAP Financial Measures” above, ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures, each of which excludes stock-based compensation (SBC) from the equivalent GAAP financial line items. In addition, non-GAAP net income attributable to ACM Research, Inc., and basic and diluted earnings per share exclude non-cash change in fair value of financial liabilities and unrealized gain on trading securities. The following table reconciles gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share to the related non-GAAP financial measures:
Three Months Ended December 31, | ||||||||||||||||||||||||||
2021 | 2020 | |||||||||||||||||||||||||
Actual | SBC | Other non-operating adjustments | Adjusted | Actual | SBC | Other non-operating adjustments | Adjusted | |||||||||||||||||||
(GAAP) | (Non-GAAP) | (GAAP) | (Non-GAAP) | |||||||||||||||||||||||
(In thousands, except EPS) | ||||||||||||||||||||||||||
Revenue | $ | 95,142 | $ | - | $ | - | $ | 95,142 | $ | 45,562 | $ | - | $ | - | $ | 45,562 | ||||||||||
Cost of revenue | (49,696 | ) | (108 | ) | - | (49,588 | ) | (25,888 | ) | (43 | ) | - | (25,845 | ) | ||||||||||||
Gross profit | 45,446 | (108 | ) | - | 45,554 | 19,674 | (43 | ) | - | 19,717 | ||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||||
Sales and marketing | (9,273 | ) | (402 | ) | - | (8,871 | ) | (5,249 | ) | (704 | ) | - | (4,545 | ) | ||||||||||||
Research and development | (12,914 | ) | (314 | ) | - | (12,600 | ) | (5,878 | ) | (195 | ) | - | (5,683 | ) | ||||||||||||
General and administrative | (4,133 | ) | (470 | ) | - | (3,663 | ) | (3,115 | ) | (363 | ) | - | (2,752 | ) | ||||||||||||
Income from operations | $ | 19,126 | $ | (1,294 | ) | $ | - | $ | 20,420 | $ | 5,432 | $ | (1,305 | ) | $ | - | $ | 6,737 | ||||||||
Unrealized gain (loss) on trading securities | (1,210 | ) | - | (1,210 | ) | - | 3,604 | - | 3,604 | - | ||||||||||||||||
Net income attributable to ACM Research, Inc. | $ | 15,565 | $ | (1,294 | ) | $ | (1,210 | ) | $ | 18,069 | $ | 8,529 | $ | (1,305 | ) | $ | 3,604 | $ | 6,230 | |||||||
Basic EPS | $ | 0.80 | $ | 0.93 | $ | 0.46 | $ | 0.34 | ||||||||||||||||||
Diluted EPS | $ | 0.70 | $ | 0.81 | $ | 0.39 | $ | 0.29 | ||||||||||||||||||
Year Ended December 31, | ||||||||||||||||||||||||||
2021 | 2020 | |||||||||||||||||||||||||
Actual | SBC | Other non-operating adjustments | Adjusted | Actual | SBC | Other non-operating adjustments | Adjusted | |||||||||||||||||||
(GAAP) | (Non-GAAP) | (GAAP) | (Non-GAAP) | |||||||||||||||||||||||
(In thousands, except EPS) | ||||||||||||||||||||||||||
Revenue | $ | 259,751 | $ | - | $ | - | $ | 259,751 | $ | 156,624 | $ | - | $ | - | $ | 156,624 | ||||||||||
Cost of revenue | (144,895 | ) | (397 | ) | - | (144,498 | ) | (87,025 | ) | (175 | ) | - | (86,850 | ) | ||||||||||||
Gross profit | 114,856 | (397 | ) | - | 115,253 | 69,599 | (175 | ) | - | 69,774 | ||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||||
Sales and marketing | (26,733 | ) | (1,802 | ) | - | (24,931 | ) | (16,773 | ) | (1,199 | ) | - | (15,574 | ) | ||||||||||||
Research and development | (34,207 | ) | (1,115 | ) | - | (33,092 | ) | (19,119 | ) | (763 | ) | - | (18,356 | ) | ||||||||||||
General and administrative | (15,214 | ) | (1,803 | ) | - | (13,411 | ) | (12,215 | ) | (3,491 | ) | - | (8,724 | ) | ||||||||||||
Income from operations | $ | 38,702 | $ | (5,117 | ) | $ | - | $ | 43,819 | $ | 21,492 | $ | (5,628 | ) | $ | - | $ | 27,120 | ||||||||
Change in fair value of financial liability | - | - | - | - | (11,964 | ) | - | (11,964 | ) | - | ||||||||||||||||
Unrealized gain on trading securities | 607 | - | 607 | - | 12,574 | - | 12,574 | - | ||||||||||||||||||
Net income attributable to ACM Research, Inc. | $ | 37,757 | $ | (5,117 | ) | $ | 607 | $ | 42,267 | $ | 18,780 | $ | (5,628 | ) | $ | 610 | $ | 23,798 | ||||||||
Basic EPS | $ | 1.96 | $ | 2.20 | $ | 1.03 | $ | 1.31 | ||||||||||||||||||
Diluted EPS | $ | 1.73 | $ | 1.94 | $ | 0.89 | $ | 1.12 | ||||||||||||||||||
Source: ACM Research, Inc.